The 66 references in paper D. Fomina S., L. Goryachkina A., Yu. Alekseeva G., E. Bobrikova N., Д. Фомина С., Л. Горячкина А., Ю. Алексеева Г., Е. Бобрикова Н. (2015) “Бронхиальная астма и ожирение: поиск терапевтических моделей // Bronchial asthma and obesity: search for therapeutic models” / spz:neicon:pulmonology:y:2014:i:6:p:94-102

1
Global Initiative for Asthma (GINA) Guidelines 2014. http:// www.ginasthma.org
(check this in PDF content)
2
Luskin A.T. What the asthma end points we know and love do and do not tell us.J. Allergy Clin. Immunol.2005; 115: S539–S545.
(check this in PDF content)
3
Busse W.W., Lemanske R.F. Jr. Asthma. N. Engl. J. Med. 2001; 344: 350–362.
(check this in PDF content)
4
Claessen H., Brenner H., Drath C., Arndt V. Repeated measures of body mass index and risk of health related outcomes. Eur. J. Epidemiol.2012; 27 (3): 215–224.
(check this in PDF content)
5
Dixon A.E. An Official American Thoracic Society Workshop Report: Obesity and asthma. Proc. Am. Thorac. Soc. 2010; 7: 325–335.
(check this in PDF content)
6
Burgess J.A., Walters E.H., Byrnes G.B. et al. Childhood adiposity predicts adult-onset current asthma in females: a 25-yr prospective study.Eur. Respir. J.2007; 29: 668–675.
(check this in PDF content)
7
Taylor B., Mannino D., Brownet C. et al. Body mass index and asthma severity in the National Asthma Survey. Thorax. 2008; 63 (1): 14–20.
(check this in PDF content)
8
Aaron S.D., Fergusson D., Dent R. et al. Effect of weight reduction on respiratory function and airway reactivity in obese women. Chest. 2004; 125: 2046–2052.
(check this in PDF content)
9
Moreira A., Bonini M., Garcia-Larsen V. et al. Weight loss interventions in asthma: EAACI Evidence-Based Clinical Practice Guideline (Part I). Allergy. 2013; 68: 425–439.
(check this in PDF content)
10
Gray D.S., Fujioka K. Use of relative weight and Body Mass Index for the determination of adiposity. J. Clin. Epidemiol. 1991; 44 (6): 545–550.
(check this in PDF content)
11
Flegal K.M., Ogden C.L., Wei R. et al. Prevalence of overweight in US children: comparison of US growth charts from the Centers for Disease Control and Prevention with other reference values for body mass index.Am. J. Clin. Nutr. 2001; 73 (6): 1086–1093. PMID 11382664.
(check this in PDF content)
12
Shore S.A. Obesity and asthma: possible mechanisms. J. Allergy Clin. Immunol.2008; 121: 1087–1093. Quiz 94–95.
(check this in PDF content)
13
Hallstrand T.S., Fischer M.E., Wurfel M.M. et al. Genetic pleiotropy between asthma and obesity in a communitybased sample of twins. J. Allergy Clin. Immunol.2005; 116: 1235–1241.
(check this in PDF content)
14
Beuther D.A., Weiss S.T., Sutherland E.R. Obesity and asthma. Am. J. Respir. Crit. Care Med. 2006; 174: 112–119.
(check this in PDF content)
15
Canoz M., Erdenen F., Uzun H. et al., The relationship of inflammatory cytokines with asthma and obesity. Clin. Invest. Med.2008; 31 (6): E373–E379.
(check this in PDF content)
16
Sierra-Honigmann M.R., Nath A.K., Murakami C. et al. Biological action of leptin as an angiogenic factor. Science. 1998; 281 (5383): 1683–1686.
(check this in PDF content)
17
Sood A., Ford E.S., Camargo C.A. Jr. Association between leptin and asthma in adults. Thorax. 2006; 61 (4): 300–305.
(check this in PDF content)
18
Strissel K.J., Stancheva Z., Miyoshi H. et al. Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes. 2007; 56: 2910–2918.
(check this in PDF content)
19
Alkhouri N., Gornicka A., Berk M.P. et al. Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis.J. Biol. Chem.2010; 285: 3428–3438.
(check this in PDF content)
20
Abreu Velez A.M., Dejoseph L.M., Howard M.S. HAM56 and CD68 antigen presenting cells surrounding a sarcoidal granulomatous tattoo. N. Am. J. Med. Sci.2011; 3: 475–477.
(check this in PDF content)
21
Sethi J.K., Vidal-Puig A.J. Thematic review series: Adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation.J. Lipid. Res. 2007; 48: 1253–1262.
(check this in PDF content)
22
Osborn O., Olefsky J.M. The cellular and signaling networks linking the immune system and metabolism in disease. Nat. Med.2012; 18: 363–374.
(check this in PDF content)
23
Mantovani A., Sozzani S., Locati M. et al. Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002; 23: 549–555.
(check this in PDF content)
24
Sica A., Mantovani A. Macrophage plasticity and polarization: In vivo veritas. J. Clin. Investig. 2012; 122: 787–795.
(check this in PDF content)
25
Mosser D.M. The many faces of macrophage activation. J. Leukoc. Biol.2003; 73: 209–212.
(check this in PDF content)
26
Shore S.A., Lang J.E., Kasahara D.I. et al. Pulmonary responses to subacute ozone exposure in obese vs. lean mice. J. Appl. Physiol.2009; 107 (5): 1445–1452.
(check this in PDF content)
27
Shore S.A. Obesity, airway hyperresponsiveness, and inflammation. J. Appl. Physiol. 2010; 108 (3): 735–743.
(check this in PDF content)
28
Fjeldborg K., Christiansen T., Bennetzen M. et al. The macrophage specific serum marker, soluble CD163, is increased in obesity and reduced after dietary induced weight loss. Obesity (Silver Spring). 2013; 21 (12): 2437–2443. DOI:10.1002/oby.20376.
(check this in PDF content)
29
Al-Daghri N.M., Al-Attas O.S., Bindahman L.S. et al. Soluble CD163 is associated with bodymass index and blood pressure in hypertensive obese Saudi patients. Eur. J. Clin. Invest.2012, 42, 1221–1226.
(check this in PDF content)
30
Kristiansen M., Graversen J.H., Jacobsen C. et al. Identification of the haemoglobin scavenger receptor. Nature. 2001; 409: 198–201.
(check this in PDF content)
31
Theoharides T.C., Cochrane D.E. Critical role of mast cells in inflammatory diseases and the effect of acute stress. J. Neuroimmunol.2004; 146: 1–12.
(check this in PDF content)
32
Chida Y., Hamer M., Steptoe A. A bidirectional relationship between psychosociall factors and atopic disorders: a systematic review and meta-analysis. Psychosom. Med. 2008; 70: 102–116.
(check this in PDF content)
33
Theoharides T.C., Enakuua S., Sismanopoulos N. et al. Stress contributes to asthma worsening through mast cell activation. Ann. Allergy Asthma Immunol. 2012; 109: 14–19.
(check this in PDF content)
34
Girodet P.O., Ozier A., Trian T. et al. Mast cell adhesion to bronchial smooth muscle in asthma specifically depends on CD51 and CD44 variant 6. Allergy. 2010; 65: 1004–1012.
(check this in PDF content)
35
Oh S.H., Park C.O., Wu W.H. et al. Corticotropin-releasing hormone downregulates IL-10 production by adaptive forkhead box protein 3-negative regulatory T-cells in patients with atopic dermatitis.J. Allergy Clin. Immunol.2012; 129: 151–159.
(check this in PDF content)
36
Dut R., Dizdar E.A., Birben E. et al. Oxidative stress and its determinants in the airways of children with asthma. Allergy. 2008; 63 (12): 1605–1609.
(check this in PDF content)
37
Sackesen C., Ercan H., Dizdar E. et al. A comprehensive evaluation of the enzymatic and nonenzymatic antioxidant systems in childhood asthma.J. Allergy Clin. Immunol. 2008; 122 (1): 78–85.
(check this in PDF content)
38
Ercan H., Birben E., Dizdar E.A. et al. Oxidative stress and genetic and epidemiologic determinants of oxidant injury in childhood asthma.J. Allergy Clin. Immunol. 2006; 118 (5): 1097–1104.
(check this in PDF content)
39
Lugogo N.L., Bappanad D., Kraft M. Obesity, metabolic dysregulation and oxidative stress in asthma. Biochim. Biophys. Acta. 2011; 1810 (11): 1120–1126.
(check this in PDF content)
40
Peters-Golden M., Swern A., Bird S.S. et al. Influence of body mass index on the response to asthma controller agents. Eur. Respir. J. 2006; 27: 495–503.
(check this in PDF content)
41
Beuther D.A., Sutherland E.R. Overweight, obesity, and incident asthma: a metaanalysis of prospective epidemiologic studies. Am. J. Respir. Crit. Care Med. 2007; 175: 661–666.
(check this in PDF content)
42
Castro-Rodriguez J.A., Holberg C.J., Morgan W.J. et al. Increased incidence of asthmalike symptoms in girls who become overweight or obese during the school years. Am. J. Respir. Crit. Care Med.2001; 163: 1344–1349.
(check this in PDF content)
43
Gold D.R., Damokosh A.I., Dockery D.W., Berkey C.S. Body-mass index as a predictor of incident asthma in a prospective cohort of children. Pediatr. Pulm. 2003; 36: 514–521.
(check this in PDF content)
44
Oddy W.H., Sherriff J.L., de Klerk N.H. et al. The relation of breastfeeding and body mass index to asthma and atopy in children: a prospective cohort study to age 6 years. Am. J. Public. Hlth.2004; 94: 1531–1537.
(check this in PDF content)
45
Mamun A.A., Lawlor D.A., Alati R. et al. Increasing body mass index from age 5 to 14 years predicts asthma among adolescents: evidence from a birth cohort study. Int. J. Obes. 2007; 31: 578–583.
(check this in PDF content)
46
Kotani K., Tokunaga K., Fujioka S. et al. Sexual dimorphism of age-related changes in whole-body fat distribution in the obese.Int. J. Obes. Relat. Metab. Disord. 1994; 18: 207–212.
(check this in PDF content)
47
Harmelen V., Reynisdottir S., Eriksson P. et al. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes. 1998; 47: 913–917.
(check this in PDF content)
48
Troisi R.J., Speizer F.E., Willett W.C. et al. Menopause, postmenopausal estrogen preparations, and the risk of adult-onset asthma. A prospective cohort study. Am. J. Respir. Crit. Care Med. 1995; 152: 1183–1188.
(check this in PDF content)
49
Jensen M.E., Collins C.E. The obesity phenotype in children with asthma.Pediatr. Respir. Rev.2011; 12 (3): 152–159.
(check this in PDF content)
50
Camargo C.A. Jr, Boulet L.P., Sutherland E.R. et al. Body mass index and response to asthma therapy: Fluticasone propionate / salmeterol versus montelukast. J. Asthma. 2010; 47: 76–82.
(check this in PDF content)
51
Sutherland E.R., Lehman E.B., Teodorescu M., Wechsler M.E. Body mass index and phenotype in subjects with mild-to-moderate persistent asthma. J. Allergy Clin. Immunol.2009; 123: 1328–1334.
(check this in PDF content)
52
Peters-Golden M., Swern A., Bird S.S. et al. Influence of body mass index on the response to asthma controller agents. Eur. Respir. J. 2006; 27: 495–503.
(check this in PDF content)
53
Boulet L.P., Franssen E. Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma. Respir. Med. 2007;101: 2240–2247.
(check this in PDF content)
54
Kazaks A., Uriu-Adams J.Y., Stern J.S., Albertson T.E. No significant relationship between exhaled nitric oxide and body mass index in people with asthma. J. Allergy Clin. Immunol.2005; 116: 929–930.
(check this in PDF content)
55
Leung T.F., Li C.Y., Lam C.W. et al. The relation between obesity and asthmatic airway inflammation. Pediatr. Allergy Immunol.2004; 15: 344–350.
(check this in PDF content)
56
Telenga E.D., Tideman S.W. Obesity in asthma: more neutrophilic inflammation as a possible explanation for a reduced treatment response. Allergy. 2012; 67: 1060–1068.
(check this in PDF content)
57
Haldar P., Pavord I.D., Shaw D.E. et al. Cluster analysis and clinical asthma phenotypes. Am. J. Respir. Crit. Care Med. 2008; 178: 218–224.
(check this in PDF content)
58
Scott H.A., Gibson P.G., Garg M.L., Wood L.G. Airway inflammation is augmented byobesity and fatty acids in asthma. Eur. Respir. J. 2011; 38: 594–602.
(check this in PDF content)
59
Stream A.R., Sutherland E.R. Obesity and asthma disease phenotypes. Curr. Opin. Allergy Clin. Immunol.2012; 12: 76–81.
(check this in PDF content)
60
Horrillo R., González-Périz A., Martínez-Clemente M. et al. 5-lipoxygenase activating protein signals adipose tissue inflammation and lipid dysfunction in experimental obesity. J. Immunol. 2010;184 (7): 3978–3987.
(check this in PDF content)
61
Chakrabarti S.K., Wen Y., Dobrian A.D. et al. Evidence for activation of inflammatory lipoxygenase pathways in visceral adipose tissue of obese Zucker rats. Am. J. Physiol. Endocrinol. Metab. 2011; 300 (1): E175–E187.
(check this in PDF content)
62
Sutherland E.R., Goleva E., Jackson L.P. et al. Vitamin D levels, lung function, and steroid response in adult asthma. Am. J. Respir. Crit. Care Med. 2010; 181 (7): 699–704.
(check this in PDF content)
63
Middleton E. Jr, Kandaswami C., Theoharides T.C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease and cancer. Pharmacol. Rev. 2000; 52: 673–751.
(check this in PDF content)
64
Kimata M., Schchijo M., Miura T. et al. Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells. Clin. Exp. Allergy. 1999; 30: 501–508.
(check this in PDF content)
65
Kempuraj D., Madhappan B., Christodoulou S. et al. Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells. Br. J. Pharmacol.2005; 145: 934–944.
(check this in PDF content)
66
Deqiu Z., Kang L., Jiali Y. et al. Luteolin inhibits inflammatory response and improves insulin sensitivity in the endothelium. Biochimie. 2011; 93: 506–512. Поступила 26.12.14 УДК 616.248!06:616!056.52
(check this in PDF content)